Will Elevated Left Ventricle Filling Pressures Decrease by a Group Exercise Program in Patients With Hypertrophic CardioMyopathy? (WEDGE-HCM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03537183|
Recruitment Status : Recruiting
First Posted : May 25, 2018
Last Update Posted : October 9, 2018
Aims and objectives: The primary objective of this study is to assess whether a structured exercise program improves cardiac relaxing properties in patients with hypertrophic cardiomyopathy (HCM).
Background: HCM is a hereditary disease in which the myocardium becomes thickened without an identifiable cause (other than genetic). It is the most common genetic cardiovascular disease with an estimated prevalence of 1/500 (i.e. 10.000 affected individuals in Denmark). The majority of patients with HCM suffers from shortness of breath and reduced exercise capacity due to increased left ventricular (LV) stiffness. Exercise training has been shown to improve exercise capacity and symptoms in patients with HCM, but the mechanisms responsible for this improvement are not known.
Methods and materials: The study is a randomized, single blinded, prospective, controlled clinical trial. Eighty patients are recruited from outpatient clinics in the Capital Region of Denmark. Patients are randomized in a 1:1 ratio to 12 week of moderate-intensity exercise training or usual activity level. Assessments will include right heart catheterization, echocardiography, cardiopulmonary exercise testing, blood-samples, quality of life, and, in a subgroup of patients, cardiac magnetic resonance imaging. The primary end-point is change in LV filling pressure assessed as pulmonary capillary wedge pressure at 25 W workload.
Expected outcome and perspectives: The investigators hypothesize that an exercise training program will reduce cardiac stiffness and improve symptoms in patients with HCM. Training of HCM patients has long been debated and the topic is poorly researched. The effects of exercise on hemodynamics in HCM patients are unknown and a better understanding of these mechanisms is pivotal for improving treatment.
|Condition or disease||Intervention/treatment||Phase|
|Hypertrophic Cardiomyopathy||Other: Exercise training||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Investigator, Outcomes Assessor)|
|Primary Purpose:||Basic Science|
|Official Title:||Will Elevated Left Ventricle Filling Pressures Decrease by a Group Exercise Program in Patients With Hypertrophic CardioMyopathy? - A Randomized Clinical Trial|
|Actual Study Start Date :||September 1, 2018|
|Estimated Primary Completion Date :||September 1, 2021|
|Estimated Study Completion Date :||September 1, 2021|
No Intervention: Usual activity level
12 weeks of usual activity level
Active Comparator: Exercise training
12 weeks of moderate intensity exercise training, 3 hours a week
Other: Exercise training
12 weeks, 3 hours a week, moderate intensity exercise training
- Change from baseline to follow-up in PCWP at 25 W [ Time Frame: 12 weeks ]Pulmonary capillary wedge pressure (mmHg)
- Pulmonary capillary wedge pressure [ Time Frame: 12 weeks ]At rest, at 25% and 50% of the maximum workload and at maximum workload ( measured as mmHg)
- Workload adjusted Pulmonary capillary wedge pressure [ Time Frame: 12 weeks ]At rest, at 25% and 50% of the maximum workload and at maximum workload, measured as mmHg/kg/W
- Systemic vascular resistance [ Time Frame: 12 weeks ]Resting and exercise systemic vascular resistance at rest, 25 W, 25% and 50% of the maximum workload and at maximum workload ( measured as mmHg)
- Exercise capacity [ Time Frame: 12 weeks ]Measured as watt at maximum workload
- Heart rate [ Time Frame: 12 weeks ]At rest, during exercise and at maximum exercise capacity (beats/min)
- Blood pressure [ Time Frame: 12 weeks ]At rest, at maximum workload, 6 minutes after cease of workload (mmHg)
- Cardiac index [ Time Frame: 12 weeks ]At rest, 25W and at maximum workload (L/min/m2):
- Arterio-venous difference [ Time Frame: 12 weeks ]At rest, 25W and at maximum workload (ml O2/L)and workload corrected (mlO2/L/W)
- VO2 max [ Time Frame: 12 weeks ]Measered as ml O2/min/kg
- Quality of life questionnaire [ Time Frame: 12 weeks ]Measured by Kansas City Cardiomyopathy score
- NT-Pro-BNP [ Time Frame: 12 weeks ](pmol/L)
- Troponin-T [ Time Frame: 12 weeks ](mmol/L)
- Echocardiographic parameters [ Time Frame: 12 weeks ]At rest: E/e'-ratio, E/A-ratio, deceleration time, LVOT gradient (mmHg). During exercise from 25W to maximum workload: E/e'-ratio, E/A-ratio, deceleration time, LVOT gradient(mmHg).
- Left ventricular fibrosis [ Time Frame: 12 weeks ](assessed as late gadolinum enhancement) and extracellular volume (assessed using T1-mapping) will be assessed in the subgroup of patients without contraindications to CMR and will be correlated to LV filling pressures.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03537183
|Contact: Helga L Gudmundsdottir, MD||40632147 ext firstname.lastname@example.org|
|Copenhagen, Denmark, 2100|
|Contact: Helga L Gudmundsdottir 40632147 email@example.com|